Q BioMed Inc
Change company Symbol lookup
Select an option...
QBIO Q BioMed Inc
VORB Virgin Orbit Holdings Inc
LBTYA Liberty Global PLC
TDOC Teladoc Health Inc
BRSH Bruush Oral Care Inc
RNA Avidity Biosciences Inc
ATAI ATAI Life Sciences NV
VTI Vanguard Total Stock Market Index Fund ETF Shares
AMPS Altus Power Inc
BPTS Biophytis SA

Health Care : Biotechnology |
Company profile

Q BioMed, Inc. is a biomedical acceleration and development company. The Company focuses on licensing, acquiring and providing strategic resources to life sciences and healthcare companies. Q BioMed acquires assets across healthcare related products, companies and sectors. It has portfolio of five therapeutic products, including Strontium-89 and MetastronTM for metastatic bone cancer pain and three development stage products: QBM-001 for rare pediatric non-verbal autism spectrum disorder; Uttroside-B for liver cancer, and MAN 01 for glaucoma. Its MAN platform has therapeutics in development in various indications, including vascular and infectious diseases. It holds license for a generic drug, Strontium Chloride (SR89). SR89 is a radiopharmaceutical agent and indicated for the treatment of bone cancer. The infectious diseases that it can treat includes influenza, COVID-19, Ebola and others. The Company's subsidiaries include Q BioMed Cayman SEZC and QBMG Q BioMed Germany UG.

Closing Price
Day's Change
0.00 (0.00%)
B/A Size
Day's High
Day's Low
(Heavy Day)

10-day average volume:
  • Prev Close
  • Today's Open
  • Day's Range
  • Avg Vol (10-day)
  • Last (time)
    1:00p ET 03/30/23
  • Last (size)
  • 52-Wk Range
    0.0047 - 0.47
  • (05/02/22 - 02/07/23)
  • 245.9%
  • Market Cap
  • Shares Outstanding
  • -0.24
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 2.2
  • 0.00
  • --

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.